Download PDF
Pädiatrie up2date 2010; 5(1): 59-78
DOI: 10.1055/s-0029-1215408
Rheumatologie

© Georg Thieme Verlag KG Stuttgart · New York

Chronisch entzündliche Gelenkerkrankungen

Teil 2: Subtypen der juvenilen idiopathischen ArthritisF.  Weller, H.-I.  Huppertz
Further Information

Publication History

Publication Date:
22 March 2010 (online)

Also available at
   
Podcasts
  Permissions and Reprints All articles of this category

Previous part of this series:

Chronisch entzündliche Gelenkerkrankungen – Allgemeine AspektePädiatrie up2date 2009; 4(04): 351-370
DOI: 10.1055/s-0029-1215281

Fortsetzung des Beitrags: F. Weller, H.-I. Huppertz. Chronisch entzündliche Gelenkerkrankungen – Allgemeine Aspekte. Pädiatrie up2date 2009; 4: 351 – 370.

Literatur

  • 1 Heiligenhaus A, Niewerth M, Ganser G. et al . Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines.  Rheumatology (Oxford). 2007;  46 (6) 1015-1019
    CrossrefGoogle Scholar
  • 2 Al-Matar M J, Petty R E, Tucker L B. et al . The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis.  Arthritis Rheum. 2002;  46 (10) 2708-2715
    CrossrefGoogle Scholar
  • 3 Padeh S, Passwell J H. Intraarticular corticosteroid injection in the management of children with chronic arthritis.  Arthritis Rheum. 1998;  41 (7) 1210-1214
    CrossrefGoogle Scholar
  • 4 Ruperto N, Murray K J, Gerloni V. et al . A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.  Arthritis Rheum. 2004;  50 2191-2201
    CrossrefGoogle Scholar
  • 5 Horneff G. et al .Experience with Etanercept in 1014 patients with juvenile idiopathic arthritis. EULAR Congress Kopenhagen. 2009
    Google Scholar
  • 6 Lovell D J. et al . Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials Organisation.  N Engl J Med. 2008;  359 (8) 810-820
    CrossrefGoogle Scholar
  • 7 Ruperto N, Lovell D J, Cuttica R. et al . A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Paediatric Rheumatology International Trials Organisation; Pediatric Rheumatology Collaborative Study Group.  Arthritis Rheum. 2007;  56 (9) 3096-3106
    CrossrefGoogle Scholar
  • 8 Lahdenne P, Vahasalo P, Honkanen V. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study.  Ann Rheum Dis. 2003;  62 (3) 245-247
    CrossrefGoogle Scholar
  • 9 Ruperto N, Lovell D J, Quartier P. et al . Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Paediatric Rheumatology International Trials Organization; Pediatric Rheumatology Collaborative Study Group.  Lancet. 2008;  372 (9636) 383-391
    CrossrefGoogle Scholar
  • 10 García-Consuegra Molina J. et al . Macrophage activation syndrome and juvenile idiopathic arthritis. A multicenter study.  An Pediatr (Barc.). 2008;  68 (2) 110-116
    CrossrefGoogle Scholar
  • 11 Singh G, Athreya B H, Fries J F. et al . Measurement of health status in children with juvenile rheumatoid arthritis.  Arthritis Rheum. 1994;  37 (12) 1761-1769
    CrossrefGoogle Scholar
  • 12 Silverman E D, Cawkwell G D, Lovell D J. et al . Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group.  J Rheumatol. 1994;  21 (12) 2353-2358
    Google Scholar
  • 13 Gattorno M, Piccini A, Lasiglie D. et al . The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis.  Arthritis Rheum. 2008;  58 (5) 1505-1515
    CrossrefGoogle Scholar
  • 14 Yokota S, Imagawa T, Mori M. et al . Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.  Lancet. 2008;  371 (9617) 998-1006
    CrossrefGoogle Scholar
  • 15 Brinkman D M, de Kleer I M, ten Cate R. et al . Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.  Arthritis Rheum. 2007;  56 (7) 2410-2421
    CrossrefGoogle Scholar
  • 16 Ravelli A, De Benedetti F, Viola S. et al . Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.  J Pediatr. 1996;  128 (2) 275-278
    Google Scholar
  • 17 Roberton D M, Cabral D A, Malleson P N. et al . Juvenile psoriatricarthritis: follw-up and evaluation of diagnostic criteria.  J Rheumatol. 1996;  23 (1) 166-170
    CrossrefGoogle Scholar
  • 18 Mease P J, Kivitz A J, Burch F X. et al . Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.  Arthritis Rheum. 2004;  50 (7) 2264-2272
    CrossrefGoogle Scholar

Frank Weller

Prof.-Hess-Kinderklinik Klinikum Bremen-Mitte

St.-Jürgen-Str. 1
28177 Bremen

Phone: 0421/497 54 11

Fax: 0421/497 33 11

Email: frank.weller@klinikum-bremen-mitte.de

      >